APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Azacitidine Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Azacitidine Drug Industry Growth and Trends Forecast to 2032

Report ID 173968570122 December 2025103 pages

Choose your research edition.

Industry ResearchAzacitidine Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Azacitidine Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Azacitidine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azacitidine Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Azacitidine Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Azacitidine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azacitidine Drug include Accord Healthcare, Celgene, Dr. Reddy's Laboratories, EVER Pharma, Getwell Oncology, MBA Pharmaceuticals Pvt Ltd, Natco Pharma, Rizochem Pharmaceutical and Shilpa Medicare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Azacitidine Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Azacitidine Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Azacitidine Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Azacitidine Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Azacitidine Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Azacitidine Drug Market by Company

Accord Healthcare

Celgene

Dr. Reddy's Laboratories

EVER Pharma

Getwell Oncology

MBA Pharmaceuticals Pvt Ltd

Natco Pharma

Rizochem Pharmaceutical

Shilpa Medicare

Shubham Pharmaceutical

Taj Generics

Xpreza

Mylan

Azacitidine Drug Segment by Type

Vidaza®

Generic Vidaza®

Azacitidine Drug Segment by Application

Chronic myelomonocytic leukemia (CMMoL)

Refractory anemia (RA)

Refractory anemia with excess blasts (RAEB)

Others

Azacitidine Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azacitidine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azacitidine Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Azacitidine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vidaza® Table 2. Major Company of Generic Vidaza® Table 3. Global Azacitidine Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Azacitidine Drug Sales by Type (2021-2026) & (k units) Table 5. Global Azacitidine Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Azacitidine Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Azacitidine Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Azacitidine Drug Price by Type (2021-2026) & (US$/unit) Table 9. Global Azacitidine Drug Sales by Type (2027-2032) & (k units) Table 10. Global Azacitidine Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Azacitidine Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Azacitidine Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Azacitidine Drug Price by Type (2027-2032) & (US$/unit) Table 14. North America Azacitidine Drug Sales by Type (2021-2026) & (k units) Table 15. North America Azacitidine Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Azacitidine Drug Sales by Type (2021-2026) & (k units) Table 17. Europe Azacitidine Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Azacitidine Drug Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Azacitidine Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Azacitidine Drug Sales by Type (2021-2026) & (k units) Table 21. Latin America Azacitidine Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Azacitidine Drug Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Azacitidine Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Azacitidine Drug Industry Trends Table 25. Azacitidine Drug Industry Drivers Table 26. Azacitidine Drug Industry Opportunities and Challenges Table 27. Azacitidine Drug Industry Restraints Table 28. Global Azacitidine Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Azacitidine Drug Revenue Market Share by Company (2021-2026) Table 30. Global Azacitidine Drug Sales by Company (2021-2026) & (k units) Table 31. Global Azacitidine Drug Sales Share by Company (2021-2026) Table 32. Global Azacitidine Drug Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Azacitidine Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Azacitidine Drug Major Company Production Sites and Headquarters Table 35. Global Azacitidine Drug Company, Product Type & Application Table 36. Global Azacitidine Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Azacitidine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Azacitidine Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Azacitidine Drug Sales by Region (2021-2026) & (k units) Table 41. Global Azacitidine Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Azacitidine Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Azacitidine Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Azacitidine Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Azacitidine Drug Sales by Region (2027-2032) & (k units) Table 46. Global Azacitidine Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Azacitidine Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Azacitidine Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Azacitidine Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Azacitidine Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Azacitidine Drug Sales by Application (2021-2026) & (k units) Table 52. Global Azacitidine Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Azacitidine Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Azacitidine Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Azacitidine Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Azacitidine Drug Sales by Application (2027-2032) & (k units) Table 57. Global Azacitidine Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Azacitidine Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Azacitidine Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Azacitidine Drug Price by Application (2027-2032) & (US$/unit) Table 61. North America Azacitidine Drug Sales by Application (2021-2026) & (k units) Table 62. North America Azacitidine Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Azacitidine Drug Sales by Application (2021-2026) & (k units) Table 64. Europe Azacitidine Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Azacitidine Drug Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Azacitidine Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Azacitidine Drug Sales by Application (2021-2026) & (k units) Table 68. Latin America Azacitidine Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Azacitidine Drug Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Azacitidine Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Accord Healthcare Company Information Table 72. Accord Healthcare Business Overview Table 73. Accord Healthcare Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Accord Healthcare Azacitidine Drug Product Portfolio Table 75. Accord Healthcare Recent Development Table 76. Celgene Company Information Table 77. Celgene Business Overview Table 78. Celgene Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Celgene Azacitidine Drug Product Portfolio Table 80. Celgene Recent Development Table 81. Dr. Reddy's Laboratories Company Information Table 82. Dr. Reddy's Laboratories Business Overview Table 83. Dr. Reddy's Laboratories Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Dr. Reddy's Laboratories Azacitidine Drug Product Portfolio Table 85. Dr. Reddy's Laboratories Recent Development Table 86. EVER Pharma Company Information Table 87. EVER Pharma Business Overview Table 88. EVER Pharma Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. EVER Pharma Azacitidine Drug Product Portfolio Table 90. EVER Pharma Recent Development Table 91. Getwell Oncology Company Information Table 92. Getwell Oncology Business Overview Table 93. Getwell Oncology Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Getwell Oncology Azacitidine Drug Product Portfolio Table 95. Getwell Oncology Recent Development Table 96. MBA Pharmaceuticals Pvt Ltd Company Information Table 97. MBA Pharmaceuticals Pvt Ltd Business Overview Table 98. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolio Table 100. MBA Pharmaceuticals Pvt Ltd Recent Development Table 101. Natco Pharma Company Information Table 102. Natco Pharma Business Overview Table 103. Natco Pharma Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Natco Pharma Azacitidine Drug Product Portfolio Table 105. Natco Pharma Recent Development Table 106. Rizochem Pharmaceutical Company Information Table 107. Rizochem Pharmaceutical Business Overview Table 108. Rizochem Pharmaceutical Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Rizochem Pharmaceutical Azacitidine Drug Product Portfolio Table 110. Rizochem Pharmaceutical Recent Development Table 111. Shilpa Medicare Company Information Table 112. Shilpa Medicare Business Overview Table 113. Shilpa Medicare Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Shilpa Medicare Azacitidine Drug Product Portfolio Table 115. Shilpa Medicare Recent Development Table 116. Shubham Pharmaceutical Company Information Table 117. Shubham Pharmaceutical Business Overview Table 118. Shubham Pharmaceutical Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Shubham Pharmaceutical Azacitidine Drug Product Portfolio Table 120. Shubham Pharmaceutical Recent Development Table 121. Taj Generics Company Information Table 122. Taj Generics Business Overview Table 123. Taj Generics Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Taj Generics Azacitidine Drug Product Portfolio Table 125. Taj Generics Recent Development Table 126. Xpreza Company Information Table 127. Xpreza Business Overview Table 128. Xpreza Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Xpreza Azacitidine Drug Product Portfolio Table 130. Xpreza Recent Development Table 131. Mylan Company Information Table 132. Mylan Business Overview Table 133. Mylan Azacitidine Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Mylan Azacitidine Drug Product Portfolio Table 135. Mylan Recent Development Table 136. North America Azacitidine Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 138. North America Azacitidine Drug Sales Market Share by Country (2021-2026) Table 139. North America Azacitidine Drug Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Azacitidine Drug Sales Market Share Forecast by Country (2027-2032) Table 141. North America Azacitidine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Azacitidine Drug Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Azacitidine Drug Market Share by Country (2021-2026) Table 144. North America Azacitidine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Azacitidine Drug Market Share Forecast by Country (2027-2032) Table 146. Europe Azacitidine Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 148. Europe Azacitidine Drug Sales Market Share by Country (2021-2026) Table 149. Europe Azacitidine Drug Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Azacitidine Drug Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Azacitidine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Azacitidine Drug Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Azacitidine Drug Market Share by Country (2021-2026) Table 154. Europe Azacitidine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Azacitidine Drug Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Azacitidine Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Azacitidine Drug Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Azacitidine Drug Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Azacitidine Drug Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Azacitidine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Azacitidine Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Azacitidine Drug Market Share by Country (2021-2026) Table 164. Asia-Pacific Azacitidine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Azacitidine Drug Market Share Forecast by Country (2027-2032) Table 166. Latin America Azacitidine Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 168. Latin America Azacitidine Drug Sales Market Share by Country (2021-2026) Table 169. Latin America Azacitidine Drug Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Azacitidine Drug Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Azacitidine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Azacitidine Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Azacitidine Drug Market Share by Country (2021-2026) Table 174. Latin America Azacitidine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Azacitidine Drug Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Azacitidine Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Azacitidine Drug Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Azacitidine Drug Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Azacitidine Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Azacitidine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Azacitidine Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Azacitidine Drug Market Share by Country (2021-2026) Table 184. Middle East and Africa Azacitidine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Azacitidine Drug Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Azacitidine Drug Distributors List Table 189. Azacitidine Drug Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Azacitidine Drug Image Figure 2. Global Azacitidine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azacitidine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Azacitidine Drug Sales (2021-2032) & (k units) Figure 5. Vidaza® Image Figure 6. Global Vidaza® Sales YoY Growth (2021-2032) & (k units) Figure 7. Generic Vidaza® Image Figure 8. Global Generic Vidaza® Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Azacitidine Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Azacitidine Drug Market Share by Type 2025 VS 2032 Figure 11. North America Azacitidine Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Azacitidine Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Azacitidine Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Azacitidine Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Azacitidine Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Azacitidine Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Azacitidine Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Azacitidine Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Azacitidine Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Azacitidine Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Azacitidine Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Chronic myelomonocytic leukemia (CMMoL) Image Figure 24. Global Chronic myelomonocytic leukemia (CMMoL) Sales YoY Growth (2021-2032) & (k units) Figure 25. Refractory anemia (RA) Image Figure 26. Global Refractory anemia (RA) Sales YoY Growth (2021-2032) & (k units) Figure 27. Refractory anemia with excess blasts (RAEB) Image Figure 28. Global Refractory anemia with excess blasts (RAEB) Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Azacitidine Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Azacitidine Drug Market Share by Application 2025 VS 2032 Figure 33. North America Azacitidine Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Azacitidine Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Azacitidine Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Azacitidine Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Azacitidine Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Azacitidine Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Azacitidine Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Azacitidine Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Azacitidine Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Azacitidine Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Azacitidine Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Azacitidine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Azacitidine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Azacitidine Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Azacitidine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Azacitidine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Azacitidine Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Azacitidine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Azacitidine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Azacitidine Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Azacitidine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Azacitidine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Azacitidine Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Azacitidine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Azacitidine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Azacitidine Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Azacitidine Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Vidaza®
  • Generic Vidaza®
Applications
  • Chronic myelomonocytic leukemia (CMMoL)
  • Refractory anemia (RA)
  • Refractory anemia with excess blasts (RAEB)
  • Others
Companies covered
  • Accord Healthcare
  • Celgene
  • Dr. Reddy's Laboratories
  • EVER Pharma
  • Getwell Oncology
  • MBA Pharmaceuticals Pvt Ltd
  • Natco Pharma
  • Rizochem Pharmaceutical
  • Shilpa Medicare
  • Shubham Pharmaceutical
  • Taj Generics
  • Xpreza
  • Mylan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Azacitidine Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Azacitidine Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Azacitidine Drug Market by Type
  6. 1.3.1 Vidaza®
  7. 1.3.2 Generic Vidaza®
  8. 1.4 Global Azacitidine Drug Market Size by Type
  9. 1.4.1 Global Azacitidine Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Azacitidine Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Azacitidine Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Azacitidine Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Azacitidine Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Azacitidine Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Azacitidine Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Azacitidine Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Azacitidine Drug Industry Trends
  2. 2.2 Azacitidine Drug Industry Drivers
  3. 2.3 Azacitidine Drug Industry Opportunities and Challenges
  4. 2.4 Azacitidine Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Azacitidine Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Azacitidine Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Azacitidine Drug Price (2021-2026)
  4. 3.4 Global Azacitidine Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azacitidine Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Azacitidine Drug Company, Product Type & Application
  7. 3.7 Global Azacitidine Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azacitidine Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azacitidine Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azacitidine Drug Tier 1, Tier 2, and Tier 3
4 Azacitidine Drug Regional Status and Outlook
  1. 4.1 Global Azacitidine Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Azacitidine Drug Historic Market Size by Region
  3. 4.2.1 Global Azacitidine Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Azacitidine Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Azacitidine Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Azacitidine Drug Forecasted Market Size by Region
  7. 4.3.1 Global Azacitidine Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Azacitidine Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Azacitidine Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Azacitidine Drug by Application
  1. 5.1 Azacitidine Drug Market by Application
  2. 5.1.1 Chronic myelomonocytic leukemia (CMMoL)
  3. 5.1.2 Refractory anemia (RA)
  4. 5.1.3 Refractory anemia with excess blasts (RAEB)
  5. 5.1.4 Others
  6. 5.2 Global Azacitidine Drug Market Size by Application
  7. 5.2.1 Global Azacitidine Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Azacitidine Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Azacitidine Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Azacitidine Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Azacitidine Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Azacitidine Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Azacitidine Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Azacitidine Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Accord Healthcare
  2. 6.1.1 Accord Healthcare Company Information
  3. 6.1.2 Accord Healthcare Business Overview
  4. 6.1.3 Accord Healthcare Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Accord Healthcare Azacitidine Drug Product Portfolio
  6. 6.1.5 Accord Healthcare Recent Developments
  7. 6.2 Celgene
  8. 6.2.1 Celgene Company Information
  9. 6.2.2 Celgene Business Overview
  10. 6.2.3 Celgene Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Celgene Azacitidine Drug Product Portfolio
  12. 6.2.5 Celgene Recent Developments
  13. 6.3 Dr. Reddy's Laboratories
  14. 6.3.1 Dr. Reddy's Laboratories Company Information
  15. 6.3.2 Dr. Reddy's Laboratories Business Overview
  16. 6.3.3 Dr. Reddy's Laboratories Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr. Reddy's Laboratories Azacitidine Drug Product Portfolio
  18. 6.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 6.4 EVER Pharma
  20. 6.4.1 EVER Pharma Company Information
  21. 6.4.2 EVER Pharma Business Overview
  22. 6.4.3 EVER Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 EVER Pharma Azacitidine Drug Product Portfolio
  24. 6.4.5 EVER Pharma Recent Developments
  25. 6.5 Getwell Oncology
  26. 6.5.1 Getwell Oncology Company Information
  27. 6.5.2 Getwell Oncology Business Overview
  28. 6.5.3 Getwell Oncology Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Getwell Oncology Azacitidine Drug Product Portfolio
  30. 6.5.5 Getwell Oncology Recent Developments
  31. 6.6 MBA Pharmaceuticals Pvt Ltd
  32. 6.6.1 MBA Pharmaceuticals Pvt Ltd Company Information
  33. 6.6.2 MBA Pharmaceuticals Pvt Ltd Business Overview
  34. 6.6.3 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolio
  36. 6.6.5 MBA Pharmaceuticals Pvt Ltd Recent Developments
  37. 6.7 Natco Pharma
  38. 6.7.1 Natco Pharma Company Information
  39. 6.7.2 Natco Pharma Business Overview
  40. 6.7.3 Natco Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Natco Pharma Azacitidine Drug Product Portfolio
  42. 6.7.5 Natco Pharma Recent Developments
  43. 6.8 Rizochem Pharmaceutical
  44. 6.8.1 Rizochem Pharmaceutical Company Information
  45. 6.8.2 Rizochem Pharmaceutical Business Overview
  46. 6.8.3 Rizochem Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Rizochem Pharmaceutical Azacitidine Drug Product Portfolio
  48. 6.8.5 Rizochem Pharmaceutical Recent Developments
  49. 6.9 Shilpa Medicare
  50. 6.9.1 Shilpa Medicare Company Information
  51. 6.9.2 Shilpa Medicare Business Overview
  52. 6.9.3 Shilpa Medicare Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shilpa Medicare Azacitidine Drug Product Portfolio
  54. 6.9.5 Shilpa Medicare Recent Developments
  55. 6.10 Shubham Pharmaceutical
  56. 6.10.1 Shubham Pharmaceutical Company Information
  57. 6.10.2 Shubham Pharmaceutical Business Overview
  58. 6.10.3 Shubham Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shubham Pharmaceutical Azacitidine Drug Product Portfolio
  60. 6.10.5 Shubham Pharmaceutical Recent Developments
  61. 6.11 Taj Generics
  62. 6.11.1 Taj Generics Company Information
  63. 6.11.2 Taj Generics Business Overview
  64. 6.11.3 Taj Generics Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Taj Generics Azacitidine Drug Product Portfolio
  66. 6.11.5 Taj Generics Recent Developments
  67. 6.12 Xpreza
  68. 6.12.1 Xpreza Company Information
  69. 6.12.2 Xpreza Business Overview
  70. 6.12.3 Xpreza Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Xpreza Azacitidine Drug Product Portfolio
  72. 6.12.5 Xpreza Recent Developments
  73. 6.13 Mylan
  74. 6.13.1 Mylan Company Information
  75. 6.13.2 Mylan Business Overview
  76. 6.13.3 Mylan Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Mylan Azacitidine Drug Product Portfolio
  78. 6.13.5 Mylan Recent Developments
7 North America by Country
  1. 7.1 North America Azacitidine Drug Sales by Country
  2. 7.1.1 North America Azacitidine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Azacitidine Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Azacitidine Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Azacitidine Drug Market Size by Country
  6. 7.2.1 North America Azacitidine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Azacitidine Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Azacitidine Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Azacitidine Drug Sales by Country
  2. 8.1.1 Europe Azacitidine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Azacitidine Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Azacitidine Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Azacitidine Drug Market Size by Country
  6. 8.2.1 Europe Azacitidine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Azacitidine Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Azacitidine Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Azacitidine Drug Sales by Country
  2. 9.1.1 Asia-Pacific Azacitidine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Azacitidine Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Azacitidine Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Azacitidine Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Azacitidine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Azacitidine Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Azacitidine Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Azacitidine Drug Sales by Country
  2. 10.1.1 South America Azacitidine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Azacitidine Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Azacitidine Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Azacitidine Drug Market Size by Country
  6. 10.2.1 South America Azacitidine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Azacitidine Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Azacitidine Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Azacitidine Drug Sales by Country
  2. 11.1.1 Middle East and Africa Azacitidine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Azacitidine Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Azacitidine Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Azacitidine Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Azacitidine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Azacitidine Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Azacitidine Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Azacitidine Drug Value Chain Analysis
  2. 12.1.1 Azacitidine Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Azacitidine Drug Production Mode & Process
  7. 12.2 Azacitidine Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Azacitidine Drug Distributors
  10. 12.2.3 Azacitidine Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst